1887

Abstract

SUMMARY

The infectivity of tissue culture-passed mouse cytomegalovirus (MCMV) for resident mouse peritoneal macrophages in the presence of serial dilutions of antiviral antibody was studied by fluorescent antibody staining and virus yields. Although MCMV was neutralized by high concentrations of antiserum, there was a twofold enhancement of infectivity by subneutralizing antibody concentrations. On further dilution of antiserum, significant neutralization appeared again. When F(ab′) fragments of anti-MCMV IgG were used or when macrophages were pretreated with monoclonal antibody to Fc receptor, there was no enhancement, and no neutralization at high dilutions of antiserum. This suggests that both enhancement and high dilution neutralization are mediated via the Fc portion of IgG and Fc receptors of macrophages. Tissue culture-passed virus whose infectivity for macrophages was reduced by high dilutions of antibody was converted to a more infectious state by addition of anti-mouse immunoglobulin. Similar results were obtained with salivary gland virus, which is less infectious for macrophages and is coated with non-neutralizing antibody. Tissue culture-passed virus is known to be less virulent for suckling mice and more infectious for macrophages than salivary gland-passed virus. When tissue culture-passed virus was coated with appropriately diluted antiviral antibody, not only was its infectivity for macrophages reduced, but it also became more virulent than control virus treated with normal mouse serum. These results are interpreted in terms of the optimal density of Fc on the virus-immunoglobulin complex in relation to the density of Fc receptors on macrophages.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-66-4-871
1985-04-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/66/4/JV0660040871.html?itemId=/content/journal/jgv/10.1099/0022-1317-66-4-871&mimeType=html&fmt=ahah

References

  1. Appel M. J. G., Mendelson S. G., Hall W. W. 1984; Macrophage Fc receptors control infectivity and neutralisation of canine distemper virus-antibody complexes. Journal of Virology 51:643–649
    [Google Scholar]
  2. Chong K. T., Gould J. J., Mims C. A. 1981; Neutralisation of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage. Archives of Virology 69:95–104
    [Google Scholar]
  3. Daughaday C. C., Brandt W. E., McCown J. M., Russell P. K. 1981; Evidence for two mechanisms of dengue virus infection of adherent human monocytes; trypsin-sensitive virus receptors and trypsin resistant immune complex receptors. Infection and Immunity 32:469–473
    [Google Scholar]
  4. Griffin F. M. Jr, Griffin J. A., Silverstein S. C. 1976; Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. Journal of Experimental Medicine 144:788–809
    [Google Scholar]
  5. Haeffner-Cavaillon N., Klein M., Dorrington K. J. 1979; Studies on the Fc receptor of the murine macrophage-like cell line P388D1. I. The binding of homologous and heterologous immunoglobulin G. Journal of Immunology 123:1905–1913
    [Google Scholar]
  6. Halstead S. B. 1980; Dengue haemorrhagic fever -a public health problem and a field for research. Bulletin of the World Health Organization 58:1–21
    [Google Scholar]
  7. Halstead S. B., Chow J. S., Marchette N. J. 1973; Immunological enhancement of dengue virus replication. Nature New Biology 243:24–26
    [Google Scholar]
  8. Hudson J. B. 1979; The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62:1–29
    [Google Scholar]
  9. Inada T., Mims C. A. 1985; Association of virulence of murine cytomegalovirus with macrophage susceptibility and with virion-bound non-neutralizing antibody. Journal of General Virology 66:879–882
    [Google Scholar]
  10. Jordan M. C., Takagi J. L. 1983; Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infection and Immunity 41:841–843
    [Google Scholar]
  11. Madsen L. H., Rodkey L. S. 1976; A method for preparing IgG F(ab′): fragment using a small amount of serum. Journal of Immunological Methods 9:355–361
    [Google Scholar]
  12. Mims C. A., Gould J. 1978; The role of macrophages in mice infected with murine cytomegalovirus. Journal of General Virology 41:141–153
    [Google Scholar]
  13. Osborn J. E., Walker D. L. 1971; Virulence and attenuation of murine cytomegalovirus. Injection and Immunity 3:228–236
    [Google Scholar]
  14. Peiris J. S. M., Porterfield J. S. 1979; Antibody-mediated enhancement of fiavivirus replication in macrophage-like cell lines. Nature, London 282:509–511
    [Google Scholar]
  15. Peiris J. S. M., Gordon S., Unkeless J. C., Porterfield J. S. 1981; Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature, London 289:189–191
    [Google Scholar]
  16. Schlesinger J. J., Brandriss M. W. 1981; Growth of 17D yellow fever virus in a macrophage-like cell line, U937, role of Fc and viral receptors in antibody-mediated infection. Journal of Immunology 127:659–665
    [Google Scholar]
  17. Selgrade M. K., Nedrud J. G., Collier A. M., Gardner D. E. 1981; Effect of cell source, mouse strain and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus. Infection and Immunity 33:840–847
    [Google Scholar]
  18. Shanley J. D., Pesanti E. L. 1983; Murine peritoneal macrophages support murine cytomegalovirus replication. Infection and Immunity 41:1352–1359
    [Google Scholar]
  19. Shaw D. R. Jr, Griffin F. M. 1981; Phagocytosis requires repeated triggering of macrophage phagocytic receptors during particle ingestion. Nature, London409–411
    [Google Scholar]
  20. Unanue E. R. 1972; The regulatory role of macrophages in antigenic stimulation. Advances in Immunology 15:95–165
    [Google Scholar]
  21. Unkeless J. C. 1979; Characterisation of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. Journal of Experimental Medicine 150:580–596
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-66-4-871
Loading
/content/journal/jgv/10.1099/0022-1317-66-4-871
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error